Nanoparticles as experimental prostate cancer treatment

Bildnummer 12638797
Nanoparticles as experimental prostate cancer treatment
Nanoparticles as experimental prostate cancer treatment. Medical imaging of prostate cancer cells (centre) and mouse models used to develop nanoparticles to treat the cancer. A protein called Prostate Specific Membrane Antigen (PSMA-1) is highly expressed by prostate cancer cells. Here, gold nanoparticles targeted to PSMA-1 selectively deliver an imaging agent and a drug called Pc4 (red, centre) to PSMA-expressing cells (blue, centre). In mice, the nanoparticles are targeted to the tumour (right, nanoparticles in red) but not healthy tissue (left). The goal of this nanotechnology is to provide surgical guidance for prostate cancer surgery, and therapeutic intervention when surgery is insufficient. This is part of an approach known as theranostics. This image was created in 2016, as part of research carried out at Case Western Reserve University, USA.
Lizenzart: Lizenzpflichtig
Credit: Science Photo Library / Case Western Reserve University / NATIONAL CANCER INSTITUTE
Bildgröße: 6000 px × 3000 px
Modell-Rechte: nicht erforderlich
Eigentums-Rechte: nicht erforderlich
Restrictions: -

Preise für dieses Bild ab 15 €

Universitäten & Organisationen
(Informationsmaterial Digital, Informationsmaterial Print, Lehrmaterial Digital etc.)
ab 15 €
Redaktionell
(Bücher, Bücher: Sach- und Fachliteratur, Digitale Medien (redaktionell) etc.)
ab 30 €
Werbung
(Anzeigen, Aussenwerbung, Digitale Medien, Fernsehwerbung, Karten, Werbemittel, Zeitschriften etc.)
ab 55 €
Handelsprodukte
(bedruckte Textilie, Kalender, Postkarte, Grußkarte, Verpackung etc.)
ab 75 €
Pauschalpreise
Rechtepakete für die unbeschränkte Bildnutzung in Print oder Online
ab 495 €

Keywords

;